智通财经获悉,香港联交所最新数据显示,9月3日,Cowin China Growth Fund II, L.P.减持银诺医药-B(02591)287万股,每股作价3.6397港元,总金额约为1044.59万港元。减持后最新持股数目约为1778.64万股,最新持股比例为4.23%。
本交易涉及其他关联方:Cowin Capital Investment Limited、Cowin Capital Investment II LTD、Cowin Capital Investment III Limited。
本文源自:智通财经网
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.